Healthcare Realty Trust Incorporated HR
18.05
0.22
1.23%
as of 25 Sep
- Market cap
- $6.1B
- P/E
- 0.0×
Follow HR
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
6.03 | 5.09 | 5.02 | 5.24 | |
P/FCF ratio |
4.89 | 4.00 | 4.06 | 4.66 | |
P/Operating CF |
48.56 | 111.64 | 44.80 | 55.47 | |
P/B ratio |
1.62 | 1.31 | 1.27 | 1.33 | |
Price to Tangible BV |
1.86 | 1.50 | 1.44 | 1.51 | |
EV/Sales |
6.08 | 5.13 | 5.06 | 5.27 | |
EV/EBITDA |
10.39 | 8.87 | 8.78 | 6.85 | |
EV/Operating CF |
15.78 | 12.87 | 13.07 | 13.70 | |
EV/FCF |
4.93 | 4.04 | 4.09 | 4.68 | |
Quick Ratio |
0.00 | 0.01 | 0.01 | 0.01 | |
Current Ratio |
0.00 | 0.01 | 0.01 | 0.01 | |
Net Debt/EBITDA |
0.33 | 0.29 | 0.28 | 0.17 | |
Debt/Assets |
0.82% | 0.81% | 0.79% | 0.74% | |
Debt/Equity |
0.02 | 0.02 | 0.02 | 0.02 | |
Asset Turnover |
0.12 | 0.12 | 0.12 | 0.11 | |
Operating CF/Net income |
(3.27) | (944.23) | 9.20 | (1.97) | |
Capex/Depreciation |
0.08 | 0.20 | 4.52 | 2.25 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.10% | 6.22% | 4.82% | 7.31% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
1.57% | 1.94% | 1.17% | 2.43% | |
Graham Net Nets |
(0.68) | (0.78) | (0.76) | (0.80) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1.29%) | (3.41%) | (4.19%) | (5.88%) | |
Free Cash Flow Yield |
20.47% | 24.98% | 24.65% | 21.46% | |
Revenue per Share |
0.82 | 0.80 | 0.82 | 0.85 | |
Operating CF per Share |
0.42 | 0.15 | 0.38 | 0.33 | |
Capex per Share |
0.03 | 0.08 | 1.75 | 0.92 | |
Free Cash Flow per Share |
0.44 | 0.23 | 2.13 | 1.25 | |
Cash per Share |
0.06 | 0.08 | 0.07 | 0.12 | |
Shareholders Equity per Share |
12.47 | 12.93 | 13.36 | 13.55 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.47 | 12.93 | 13.36 | 13.55 | |
Free Cash Flow |
152.12 | 80.08 | 743.75 | 437.06 | |
Working Capital |
(4,307.68) | (4,215.39) | (4,096.32) | (4,616.14) | |
Capital Expenditures |
9.94 | 27.20 | 611.41 | 323.31 | |
Net Current Asset Value |
(4,712.62) | (4,628.26) | (4,511.32) | (5,075.79) | |
EV/EBIT |
53.83 | 56.10 | 64.32 | 20.54 | |
Capex to Sales |
(0.04) | (0.10) | (2.14) | (1.09) | |
Net Profit Margin |
(15.44%) | (0.02%) | 5.03% | (19.39%) | |
Price to Operating Income |
53.40 | 55.65 | 63.82 | 20.45 | |
| Other line items | |||||
Average Payables |
176.90 | 141.28 | 216.79 | 185.61 | |
Average Assets |
9,618.36 | 9,822.22 | 9,930.89 | 10,552.11 | |
Average Common Equity |
4,573.32 | 4,817.94 | 4,987.23 | 5,167.99 |
Columns are period end dates